Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-21

Clinical Trial Update: Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate Intake [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of Technosphere Insulin Inhalation Powder at an optimal dose with varied carbohydrate intake in Type 1 and Type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Technosphere Insulin Inhalation Powder (insulin inhalation powder)

Snippet

Sponsor: Mannkind Corporation | Conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1 | Phase 2 | Status: TERMINATED | Results posted: 2014-10-21